Login

Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Jun 30, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Jan 31, 2022
Current assets
Cash
Prepaid expenses
Accrued interest receivable
Total Current Assets
Non-current prepaid expenses
Non-current Investment held in Trust Account
TOTAL ASSETS
Current liabilities
Accrued expenses and accounts payable
Notes payable
Convertible note payable
Due to Related Party
Total current liabilities
Deferred underwriting fees payable
Warrant liabilities
Total Liabilities
Class A ordinary shares; 520,056 shares subject to possible redemption as of March 31, 2025 and December 31, 2024, at redemption value outstanding
Class A Ordinary Shares
Total class A ordinary shares; 520,056 shares subject to possible redemption as of March 31, 2025 and December 31, 2024, at redemption value outstanding
Shareholders’ Deficit
Preferred Stock - $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of March 31, 2025 and December 31, 2024
Common stock, value
Class A Ordinary Shares
Class B Ordinary Shares
Additional paid-in capital
Accumulated Deficit
Total Shareholders’ Deficit
TOTAL LIABILITIES, CLASS A ORDINARY SHARE SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support